🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Sabra Health Care REIT, Inc.

SBRA Real Estate
$20.82 +$0.35 (1.71%)
Market Cap: $5.32 B
Gurus Holding
6
Popularity Rank
#1544
% of Shares Held
1.48%
Net Activity (Q2 2026)
+$33.71 M

Guru Ownership Trend

Guru Analysis for Sabra Health Care REIT, Inc. (SBRA)

Sabra Health Care REIT, Inc. (SBRA), a key player in the Real Estate sector, continues to attract institutional attention.

As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $78.73 M.

Top institutional holders include Cliff Asness and Steven Cohen.

Institutional sentiment is currently Bullish. This is evidenced by a $33.71 M net inflow during the quarter.

Recent activity highlights Paul Tudor Jones who dramatically increased their stake. Conversely, Joel Greenblatt reduced exposure by 7.8%.

Key Holders

Top 5 by Value

$39 M
$21.75 M
$12.32 M
$458,797
$239,973

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$33.75 M
Total Buy Value
New Buys 1
Additions 4
-$38,746.85
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
5

FAQs for Sabra Health Care REIT, Inc. (SBRA)

Major holders include Cliff Asness ($39 M), Steven Cohen ($21.75 M), Paul Tudor Jones ($12.32 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 3.78 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $33.71 M, with 5 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited SBRA. The total reported sell value was $38,746.85.

Yes, 1 managers opened new positions in SBRA, and 4 increased their existing holdings. The total reported buy value was $33.75 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Add 41.4% 1,998,848 $39 M Q2 2026
0.02% Add 99.0% 1,115,011 $21.75 M Q2 2026
0.02% Add 1070.4% 631,543 $12.32 M Q2 2026
0.00% Reduce -7.8% 23,516 $458,797 Q2 2026
0.00% New Buy 12,300 $239,973 Q2 2026
0.00% Add 89.1% 242 $4,724 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form